TY - JOUR
T1 - Intimate partner violence and HIV sexual risk behaviour among women who inject drugs in Indonesia
T2 - a respondent-driven sampling study
AU - Stoicescu, Claudia
AU - Cluver, Lucie D.
AU - Spreckelsen, Thees
AU - Casale, Marisa
AU - Sudewo, Anindita Gabriella
AU - Irwanto, null
N1 - Funding Information:
Funding Funding was provided by Canadian Institutes of Health Research (Grant No. 314721), Pierre Elliott Trudeau Foundation, Asian Network of People Living with HIV and Australian Injecting and Illicit Drug Users League.
Funding Information:
This study would not have been possible without the participation of the courageous women who shared their experiences with us. The authors gratefully acknowledge the contributions of the Perempuan Bersuara research team: Rima Ameilia, Rika Nasution, Merry Christina, Ratu Tatiek, Mumpuni, Dwi Surya, Mira Febriyanti, Putty Sekar Melati, and Putri Tanjung. We are grateful to Indonesian Network of People Who Use Drugs secretariat for hosting community consultations and piloting, providing a project office, and supporting data collection. We wish to thank Matthias Schonlau, University of Waterloo, for his guidance and trouble-shooting with RDS analysis, and Evgenia (Jane) Milman, McGill University, for her valuable thoughts on an earlier version of this manuscript.
Publisher Copyright:
© 2018, The Author(s).
PY - 2018/10
Y1 - 2018/10
N2 - Women who inject drugs are disproportionately affected by HIV and intimate partner violence (IPV); however, the link between IPV and HIV remains under-researched among substance-using women in low- and middle-income countries. This study examined associations and additive effects of different forms of IPV victimization (psychological, physical and/or injurious, and sexual) on HIV sexual risk behavior among women who inject drugs in Indonesia. Respondent-driven sampling (RDS) was used to recruit 731 women from Greater Jakarta and Bandung, West Java. RDS-II weighted prevalence of any past-year IPV was 68.9% (95% CI 65.0, 72.6) in Jakarta and 55.9% (95% CI 48.0, 63.5) in Bandung. In separate logistic regressions controlling for socio-demographic covariates, all three forms of IPV showed statistically significant associations with sexual risk behavior. After adjusting for all IPV types, psychological (OR 1.87; 95% CI 1.17, 2.99; p = 0.009) and sexual (OR 1.98; 95% CI 1.22, 3.21; p = 0.006) IPV independently predicted women’s sexual risk behavior. Marginal effects models suggested that co-occurrence of multiple forms of IPV had greater adverse consequences: sexual risk behavior was reported by 64.1% of women who did not experience any IPV, but increased to 89.9% among women exposed to all three types. Comprehensive harm reduction services that integrate IPV monitoring and prevention are urgently needed to reduce both HIV and IPV.
AB - Women who inject drugs are disproportionately affected by HIV and intimate partner violence (IPV); however, the link between IPV and HIV remains under-researched among substance-using women in low- and middle-income countries. This study examined associations and additive effects of different forms of IPV victimization (psychological, physical and/or injurious, and sexual) on HIV sexual risk behavior among women who inject drugs in Indonesia. Respondent-driven sampling (RDS) was used to recruit 731 women from Greater Jakarta and Bandung, West Java. RDS-II weighted prevalence of any past-year IPV was 68.9% (95% CI 65.0, 72.6) in Jakarta and 55.9% (95% CI 48.0, 63.5) in Bandung. In separate logistic regressions controlling for socio-demographic covariates, all three forms of IPV showed statistically significant associations with sexual risk behavior. After adjusting for all IPV types, psychological (OR 1.87; 95% CI 1.17, 2.99; p = 0.009) and sexual (OR 1.98; 95% CI 1.22, 3.21; p = 0.006) IPV independently predicted women’s sexual risk behavior. Marginal effects models suggested that co-occurrence of multiple forms of IPV had greater adverse consequences: sexual risk behavior was reported by 64.1% of women who did not experience any IPV, but increased to 89.9% among women exposed to all three types. Comprehensive harm reduction services that integrate IPV monitoring and prevention are urgently needed to reduce both HIV and IPV.
KW - HIV
KW - Injecting drug use
KW - Intimate partner violence
KW - Respondent-driven sampling
KW - Sexual risk behavior
KW - Women
UR - https://www.scopus.com/pages/publications/85048375934
U2 - 10.1007/s10461-018-2186-2
DO - 10.1007/s10461-018-2186-2
M3 - Article
C2 - 29948336
AN - SCOPUS:85048375934
SN - 1090-7165
VL - 22
SP - 3307
EP - 3323
JO - AIDS and Behavior
JF - AIDS and Behavior
IS - 10
ER -